Breath test may replace needles for COPD patients

NCT ID NCT05704881

Recruiting now Knowledge-focused Sponsor: University Hospital, Grenoble Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a non-invasive breath measurement (EtCO2) can help doctors quickly tell how serious a COPD attack is. Researchers will monitor 240 adults in the emergency room to see if EtCO2 levels can predict the need for breathing support. If successful, this could reduce painful blood draws and speed up treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXACERBATION COPD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EXACERBATION COPD PULMONARY DISEASE, CHRONIC OBSTRUCTIVE

Contacts and locations

Locations

CHU Grenoble Alpes
RECRUITING

Grenoble, Isère, 38000, France
Hospices Civils de Lyon
RECRUITING

Lyon, Rhône, 69000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.